Why Is Agios Pharmaceuticals Stock Trading Higher On Tuesday? - Agios Pharmaceuticals (NASDAQ:AGIO)

Agios Pharmaceuticals sells its 15% royalty rights on U.S. net sales of Servier's vorasidenib to Royalty Pharma for $905 million upon FDA approval.

Related Keywords

Pharma Plc , ,Agios Pharmaceuticals ,Royalty Pharma ,Prescription Drug User Fee Act ,Fatigue Score ,